ArticleCell death discovery2025

Thyroid hormones inhibit tumor progression and enhance the antitumor activity of lenvatinib in hepatocellular carcinoma via reprogramming glucose metabolism.

Chun-Cheng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.